Tissue microarray technology in the routine assessment of HER-2 status in invasive breast cancer: a prospective study of the use of immunohistochemistry and fluorescence in situ hybridization.
Graham AD, Faratian D, Rae F, Thomas JS
Purpose
The purpose of this paper was to compare human epidermal growth factor receptor 2 (HER2) immunohistochemical (IHC) staining and fluorescence in situ hybridization (FISH) between tissue microarrays (TMAs) and whole section slides of breast cancer specimens.
Conclusion
Evaluation of at least 5 TMA cores per specimen ensured the presence of at least 3 assessable cores for IHC and FISH analysis for 98% and 95% of specimens, respectively. Using the highest individual core score to determine specimen HER2 status by IHC or FISH resulted in greater agreement (78% and 97%, respectively) between TMAs and whole section slides than when individual core scores were averaged to determine a specimen score (73% and 94.6%, respectively). 96% of specimens that had a HER2 score of 3+ by TMA based IHC staining were also HER2+ by FISH, but 84% of specimens that had a HER2 score of 3+ by whole section IHC staining were HER2+ by FISH.
Studies (1)
Purpose
The purpose of this study was to compare HER2 IHC staining and FISH between TMAs and whole section slides of breast cancer specimens. Whole section specimens scored as equivocal by IHC (2+), and a subset of those scored as positive (3+) underwent subsequent FISH analysis along with corresponding TMA specimens. 6 cores were included for each of 106 specimens on the TMAs, and scoring was done for specimens with at least 3 assessable cores (103/106). Whole section analysis was repeated for discrepant results between 2 observers until an agreement was reached. The individual core scores were averaged for a TMA specimen score, or HER2 status was determined if at least one core was scored 3+ by IHC staining or had a FISH amplification ratio > 2.0 by both observers.
Summary of Findings
Only 85% and 71% of cases had three assessable TMA cores for IHC and FISH, respectively, when only 3 cores were evaluated, but when 5 cores were evaluated, 3 assessable cores were present for 98% and 95% of specimens, respectively. Complete concordance of HER2 IHC scores for whole sections and TMAs was achieved in 73% of cases when the average of all cores for each case and by each observer was used to determine status. When the highest score was used to determine status, concordance between TMA and whole section HER2 status by IHC was achieved in 78% of cases. Complete concordance in HER2 status by FISH for whole sections and TMAs was achieved in 94.6% of cases when the average of all cores for each case and by each observer was used to determine status. The two discordant cases were HER2+ on the whole section and HER2- on the TMA but were within acknowledged borderline ratios for FISH. When the highest score was used to determine status, concordance between TMA and whole section HER2 status by FISH was achieved in 97% of cases. 96% of specimens that had HER2 scores of 3+ by TMA based IHC staining were also HER2+ by FISH, while 84% of specimens that had HER2 scores of 3+ by whole section IHC staining were HER2+ by FISH.
Biospecimens
TissueBreastPreservation Types
FormalinDiagnoses
NeoplasticCarcinomaPlatforms
ProteinImmunohistochemistryDNAFISHProteinTissue microarrayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Aliquots and Components Aliquot size/volume 3 TMA cores evaluated4 TMA cores evaluated5 TMA cores evaluated6 TMA cores evaluatedBiospecimen Aliquots and Components Type of slide Tissue microarrayWhole sectionTissue microarray Specific Data handling Cores averagedHighest core scoreFISH Specific Targeted nucleic acid CEN17HER2Immunohistochemistry Specific Targeted peptide/protein HER2Immunohistochemistry Specific Technology platform FISH